These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3840172)

  • 1. High-performance liquid chromatographic assay of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo-[4,5-c] pyridine hydrochloride, a potent cardiotonic agent, and two metabolites in plasma.
    Bernstein JR; Franklin RB
    J Chromatogr; 1985 Jul; 342(1):228-33. PubMed ID: 3840172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of blood levels, excretion and metabolite pattern in rats non-pretreated and pretreated with subacute doses of AR-L 115 BS].
    Busch U
    Arzneimittelforschung; 1981; 31(1a):209-12. PubMed ID: 7195223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine.
    Robertson DW; Beedle EE; Krushinski JH; Pollock GD; Wilson H; Wyss VL; Hayes JS
    J Med Chem; 1985 Jun; 28(6):717-27. PubMed ID: 4009593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species].
    Roth W; Prox A; Reuter A; Schmid J; Zimmer A; Zipp H
    Arzneimittelforschung; 1981; 31(1a):232-5. PubMed ID: 7195228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid, sensitive and fully automated high-performance liquid chromatographic assay with fluorescence detection for sulmazole and metabolites.
    Roth W
    J Chromatogr; 1983 Dec; 278(2):347-57. PubMed ID: 6668315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of cardiotonic agent MDL 17,043 in plasma by reversed-phase high-performance liquid chromatography.
    Chan KY; Lang JF; Okerholm RA
    J Chromatogr; 1983 Feb; 272(2):396-400. PubMed ID: 6220024
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
    Mierau J
    Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of 4,5-dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3(2H)-pyridazinone hydrochloride, a new cardiotonic, in plasma and urine by reversed-phase high-performance liquid chromatography.
    Hayes AG; Mehta S; Chang T
    J Chromatogr; 1984 Dec; 336(2):446-51. PubMed ID: 6530478
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of AR-L 115 BS in the rat (author's transl)].
    Busch U
    Arzneimittelforschung; 1981; 31(1a):204-9. PubMed ID: 7195222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous analysis of a new cardiotonic agent, MDL 17,043, and its major sulfoxide metabolite in plasma by high-performance liquid chromatography.
    Chan KY; Ohlweiler DF; Lang JF; Okerholm RA
    J Chromatogr; 1984 Mar; 306():249-56. PubMed ID: 6232282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of AR-L 115 BS in rabbits and dogs].
    Zimmer A; Hammer R
    Arzneimittelforschung; 1981; 31(1a):212-6. PubMed ID: 7195224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic activity of different doses of sulmazole by infusion.
    Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
    Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of enoximone and its principle metabolite in serum and urine using high pressure liquid chromatography].
    Tarral E; Jehl F; Gallion C; Monteil H
    Therapie; 1990; 45(1):1-6. PubMed ID: 2140472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method of analysis of the new cardiotonic agent, MDL 19,205, in plasma and urine and its application in a dog pharmacokinetic study.
    Keeley FJ; Theile JD; Garteiz DA; Weiner DL; Okerholm RA
    J Chromatogr; 1983 Dec; 278(2):379-85. PubMed ID: 6668317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicological evaluation of the cardiotonic isomazole in the dog.
    Means JR; Franklin RB; Sandusky GE
    Fundam Appl Toxicol; 1989 Oct; 13(3):418-28. PubMed ID: 2612775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human pharmacokinetics of AR-L 115 BS (author's transl)].
    Roth W; Zimmer A; Busch U
    Arzneimittelforschung; 1981; 31(1a):236-9. PubMed ID: 7195229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
    Cameron BD; Draffan GH; Dunsire JP; Zimmer A
    Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlinear pharmacokinetics of the new positive inotropic agent sulmazole in the dog.
    Garrett ER; Roth W
    J Pharm Sci; 1983 Feb; 72(2):105-16. PubMed ID: 6834245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic preparation of human serum samples for analysis of the drug enoximone and its sulphoxide metabolite using high-performance liquid chromatography.
    Cooper JD; Turnell DC
    J Chromatogr; 1986 Jul; 380(1):109-16. PubMed ID: 2943750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.